Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Journal of Atherosclerosis and Thrombosis|December 8, 2011
Atorvastatin does not affect ischaemia-induced phosphatidylserine exposition in humans in-vivoConstantijn W Wouters, Patrick Meijer, Carola I F Janssen, et al.
Schizophrenia Bulletin Open|August 15, 2024
Cost-Effectiveness of a Multidisciplinary Lifestyle-Enhancing Treatment for Inpatients With Severe Mental Illness: The MULTI Study VJeroen Deenik, Chris van Lieshout, Harold F van Driel, et al.
International Journal of Integrated Care|May 8, 2023
Managing the Increasing Burden of Atrial Fibrillation through Integrated Care in Primary Care: A Cost-Effectiveness AnalysisCarline J van den Dries, Miriam P van der Meulen, Geert W J Frederix, et al.
Hemasphere|February 10, 2022
Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia ARenske M T Ten Ham, Sikon M Walker, Marta O Soares, et al.
Trends in Molecular Medicine|December 17, 2017
Is It Our Duty To Hunt for Pathogenic Mutations?Roel H P Wouters, Rhodé M Bijlsma, Geert W J Frederix, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2021
Early health economic analysis of 1.5 T MRI-guided radiotherapy for localized prostate cancer: Decision analytic modellingCharisma Hehakaya, Jochem R N van der Voort van Zyp, Ben G L Vanneste, et al.
Neuroepidemiology|July 2, 2024
Toward a Useful and Cost-Effective Workup in Chronic Polyneuropathy: The EXPRESS Study ProtocolMadde Wiersma, Gerjan M van der Star, Filip Eftimov, et al.
Clinical Pharmacology and Therapeutics|January 20, 2022
The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung CancerNikki de Rouw, Merel de Boer, René J Boosman, et al.
Trials|June 20, 2018
Effectiveness of endoscopic totally extraperitoneal (TEP) hernia correction for clinically occult inguinal hernia (EFFECT): study protocol for a randomized controlled trialMarleen M Roos, Egbert-Jan M M Verleisdonk, Floris B M Sanders, et al.
Plos One|June 1, 2026
Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCEAniek E M Schouten, Geert W J Frederix, Martijn M Stuiver, et al.
Pageof 7